Clinical Trials in Washington

Showing 3941-3960 of 7,241 trials

ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis

NCT03923478

Phase 1B randomized, double-blind, placebo-controlled, two-cohort clinical trial of ABI-M201 in adult subjects with mildly-to-moderately active Ulcerative Colitis(UC) and ongoing treatment with mesalamine.

Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate

Assembly Biosciences15 participantsStarted Jun 2019

Oakland, California, United States • San Carlos, California, United States • Decatur, Georgia, United States +8 more locations

TERMINATEDPhase 336 miles

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

NCT00610935

The purpose of this study is to determine the safety and effectivess of a single intramuscular injection of peramivir for the treatment of subjects with acute, uncomplicated influenza.

Influenza

BioCryst Pharmaceuticals82 participantsStarted Jan 2008

Millbrook, Alabama, United States • Tuscaloosa, Alabama, United States • Phoenix, Arizona, United States +93 more locations

ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Find Trials by Condition in Washington

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

American Trial Using Tranexamic Acid in Thrombocytopenia

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Longitudinal Surveillance Study of the 4-SITE Lead/Header System

A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease

Selecting a Favorable KIR Donor in Unrelated HCT for AML

Induced Gingivitis & Intra-oral Imaging

Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)

AMPLEX Ankle Fusion and Hindfoot

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads